LDN was founded in 1996 in Nordhorn, Germany, with the aim to develop, manufacture and supply specialty in-vitro diagnostics test systems and innovative technologies to the clinical and research laboratory markets. From the beginning the determination of biogenic amines with immunological test systems was in the core of our business – where we are nowadays the world wide market leader. Integral part of this success are e.g. our assays for the quantitative determination of free metanephrines in plasma, the catecholamines, histamine and serotonin.
|